Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Evoke Pharma, Inc. EVOK NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
57/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$18.00
+63.6%

Evoke Pharma, Inc. (EVOK) has 12 identified peers for comparison in the Healthcare sector. Peers include ACRX, ADMP, AGRX, AKAN, AQST, AVDL and others.

EVOK has a market capitalization of $18.95M, compared to an average peer market cap of $230.68M. EVOK is notably smaller than its average peer.

People Also View

RGC
RGC
Regencell Bioscience Holdings Limited
$30.11
-6.61%
 AVDL
AVDL
Avadel Pharmaceuticals plc
$21.64
+0.00%
 AQST
AQST
Aquestive Therapeutics, Inc.
$4.15
-0.95%
 DERM
DERM
Journey Medical Corporation
$5.26
+1.15%
 PROC
PROC
Procaps Group S.A.
$1.01
+100.00%
 JUPW
JUPW
Jupiter Wellness, Inc.
$1.52
+11.76%
 CPIX
CPIX
Cumberland Pharmaceuticals Inc.
$3.18
+1.92%
 IXHL
IXHL
Incannex Healthcare Limited
$3.54
-0.28%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message